DOCSLIB.ORG

Correspondence Continuing Education for Nuclear Pharmacists

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO The University of New Mexico Correspondence Continuing Education Courses for Nuclear Pharmacists and Nuclear Medicine Professionals VOLUME 111, NUMBER 3 ● Radiopharmaceuticals for the Scintigraphic Assessment of Hepatobiliary Function by: Anne-Line Anderson, M.S, Co-sponsored by: mpi pharmacy services inc an ~mersham company ● The University of New Mexico College of Pharmacy is approved by the American Council on Pharrnaceulical Education as a provider of continuing pharmaceutical education. Program No. 180-039-93-006. 2.5 Contact Hours or .25 CEU’S M UI Editor Director of Ptimcy Continuing Education William B. Hladik III, M.S., R. Ph. College of Pharmacy University of New Mexico Production Spectiist Sharon I. Ramirez, Staff Assistant College of Pharmacy University of New Mexico While the advice and information in this publication are believed to bc true and accurate at press time, neither the author(s) nor the editor nor the publisher can accept any legal responsibility for tiny errors or omissions that may bc made. The publisher makes no warranty, express or implid, with respect to the mtiterial contained herein. Copyright 1994 University of New Mexico Phamcy Continuing Education Albuquerque, New Mexico RADIOPHARMA CEUTICALS FOR THE SCINTIGR.APHIC ASSESSMENT OF HEPATOBILL4RY FUNCTION STATEMENT OF OBJECTIVES The goal of this correspondence lesson is to increase the reader’s knowledge and understanding of current hepatobiliary radiopharmaceuticals. To that end, this course discusses hepatobiliary anatomy and finction, hepatocyte uptake, metabolism, and excretion of endogenous and exogenous compounds, and the pathway of bile excretion. In addition, gallstone formation, composition, and treatment is reviewed. The course presents information related to the development of current hepatobiliary radiopharmaceuticals, optimal characteristics of such agents, and the in vivo and in vitro properties of agents available for routine use in the U.S. This is followed by a discussion of the clinical use of hepatobiliary radiopharmaceuticals, including augmented cholescintigraphy, and a review of quantitative methods for the assessment of hepatocyte function. Upon successful completion of this mate~l, the retier shouti be able to: 1. Describe hepatobiliary anatomy and function. 2. Explain the major functions of the hepatocyte. 3. Describe the biliary uptake and excretion pathways for bile acids and organic anions. 4. List three major components of bile. 5. Explain the origin, conjugation, enterohepatic circulation and function of bile acids. ● 6. Describe the origin and excretion pathway of bilirubin and how it affects hepatocyte excretion of other organic anions. 7. Discuss the factors that affect gallbladder filling and emptying. 8. Explain the current understanding of the underlying causes for gallstone formation. 9. Explain methods used in the treatment of gallstone disease. 10. List the required chemical and pharmacologic characteristics of an ideal hepatobiliary radiopharmaceutical. 11. Discuss the development of current hepatobiliary radiopharmaceuticals. 12. Explain the role that analysis of structure-activity relationships has played in the development of improved cholescintigraphic agents. 13. List hepatobiliary radiopharmaceuticals currently available for routine use in the U.S. 14. Describe the preparation and radiochemical quality control of Tc-99m iminodiacetic acid (IDA) analogs. 15. Compare the in vivo characteristics in humans of routinely used Tc-99m IDA radiopharmaceuticals. 16. List the four organs that receive the highest absorbed radiation doses from Tc-99m iminodiacetic acid (IDA) radiopharmaceuticals. 17. Understand how drug therapy can interfere with the movement of cholescintigraphic agents through the hepatobiliary system. 18. List the principal applications for cholescintigraphy. 19, Describe how hepatobiliary imaging studies are performed. 20. Explain the three types of pharmacologic interventions used in augmented cholescintigraphy. 21. Discuss the various causes of cholecystitis. 22. Explain the two most common causes of neonatal jaundice and the role of cholescintigraphy in the ● differential diagnosis. 23. Discuss the current status of methods for quantitation of hepatocellular function. 24. Describe the hepatocyte uptake and handling of Tc-99m galactosyl-neogly coalbumin. 1 COURSE OUTLINE Ix. HEPATOBILIARY IMAGING I. INTRODUCTION A. Imaging Methods and Analysis 1. Patient Preparation II. HEPATOBILIARY ANATOMY AND 2. Imaging Technique and ● FUNCTION Analysis 111. HEPATOBILIARY PHYSIOLOGY B. Augmented Cholescintigraphy 1. Cholecystokinetic Agents A. Bile Acids 2. Morphine B. Lipids 3. Phenobarbital c. Organic Anions D. Organic Cations c. Cholecystitis E. Pathway of Bile Excretion D. Sphincter of Oddi Dysfunction F. Gallstones E. Biliary Obstruction F. Bile ~kage and Reflux IV. CHAR4CTERlSTICS OF O~IMAL G. Nanatal Jaundice ~PATOBILIARY RADIOPHAR- MACEUTICALS X. QUANTITATION OF HEPATIC FUNCTION v. DEVELOPMENT OF CURRENT A. Measurement of Hepatic Extraction ~PATOBILIARY RADIOPHAR- Fraction (HEF) Using Tc-99m IDA MACEUTICALS Analogs B. Quantitation of Hepatic Binding A. Historical Perspective Protein Rweptors B. Technetium-99m Pyridoxylidene Amino Acid Complexes c. Technetium-99m Acetanilido- iminodtacetates D. Relationship BetweerIBiodistribution RADIOPHARMACEUTICALS and Chemical Structure FOR THE SCJNTIGRAPHIC ASSESSMENT OF VI. COMMERCIALLY AVAILABLE HEPATOBILIARY FUNCTION HEPATOBILIARY RADIOPHARMACEUTICALS By: A. Agents Available in the U. S. Anne-Line Anderson, M.S. B. Radiochemical Quality Control Clinical Professor of Radiological Sciences Methods Department of Radiological Sciences c. In Vitro Stability ‘Division of Nucledr Medicine D. Pharmacoklnetics in Humans University of California, Irvine, Medical Center Orange, California VII. RADIATION DOSIMETRY VIII. PRECAUTIONS INTRODUCTION A. Drug Interference 1. Narcotic Analgesics He~atohiliary radiopharmaceuti cals are an 2. Nicotinic Acid . important adjunct in the differential diagnosis of acute 3. Total Parenteral Nutrition Due to the excellent (TPN) Therapy and chronic abdominal pain. 4. Miscellaneous Drugs physical and biological properties of current Tc-99m labeled radiopharmaceuticals, cholescintigraph y is B. Adverse Reactions considered to be both a noninvasive and very sensitive c. Use During Pregnancy and in Nursing test for evaluation of the functional Sbdtusof the cystic Mothers duct and the gallbladder. Hepatobiliary imaging can also be helpful in the differentiation between surgical 2 and medical jaundice, and it is an excellent method for blood by the hepatocytes, including bile acids and visualizing the pathway of bile following surgery or bilirubin. The alternate pathway of excretion is trauma. The greatwt impact has been on the secretion back into plasma and subsequent clearance diagnostic evaluation of suspected acute. cholecystitis by the kidneys. The biliary excretory system begins ● (l). More than 90% of cases of acute cholecystitis with the bile canalicular network, which drains into a result from cystic duct obstruction by gallstones, series of progressively larger ducts that eventually which cause stasis in the gallbladder followed by combine to form the common hepatic duct. This is chemically-induced inflammation and mucosal injury joined by the cystic duct from the gallbladder to form (2). Biliary tract disease caused by gallstones the common bile duct, which empties into the (cholelithiasis) is a major mdical and surgical duodenum through the sphincter of Oddi. Just prior problem in many parts of the world. It is estimated to entering the duodenum, the common biIe duct is that 20 million individuals in the United States have usually joined by the pancreatic duct. During fasting, gallstones. Although gallstones do not cause bile is diverted into the gallbladder where it is symptoms in the majority of individuals, gallstone- concentrated and stored. In response to a meal, the related disease afflicts up to two million Americans sphincter of Oddi relaxes, the gallbladder contracts, annual]y, leading to direct health care costs exceeding and concentrated bile empties into the duodenum. $2 billion per year. Cholelithimis is the most common single indication for abdominal surgery in the HEPATOBILIARY PHYSIOLOGY United States, with around 500,000 cholecystectomies performed annually (2). The epidemiology, symptoms, The first step in hepatobiliary excretion is up~dke diagnostic workup, and available treatment for across the hepatocyte membrane. Receptor binding cholecystitis and some other abnormalities of the sites on the sinusoidal plasma membrane of hepatohiliary system will he reviewed in the following hepatocytes are responsible for selective uptake of a sections. variety of endogenous and exogenous compounds. Specific carrier-mediated active transport systems HEPATOBILIARY ANATOMY AND FUNCTION appear to exist for various classes of compounds such as organic anions, bile acids, organic cations, and ● The 1iver is tie largest organ in the body, weighing neutral organic compounds (3,5), Distinct transpofi 1200-1600 g in normal adults. The hepatic mechanisms exist for inorganic ions as well; the parenchyma contains a complex network of blood transport of these ions in and out of hepatocytes is vessels and excretory ducts. The liver has dual blood regulated by various “pumps” that maintain conditions supply with about 80% coming from the G.I. tract via required
Recommended publications
  • Italy and Ligurian Regional HTA Network Abstract Number: 169775

    Italy and Ligurian Regional HTA Network Abstract Number: 169775

    Abstract Number: 169775 Mini HTA: an effective tool for clinical governance, resource allocation and conflict management at local (Regional) level. Gaddo Flego MD, Francesco Cardinale MD, ASL Nr 4 "Chiavarese", Italy and Ligurian Regional HTA Network The Italian National Health System is centrally governed by the Ministry of Health and by Local Health Authorities (ASL) at Regional level. The Region of Liguria is divided into 5 ASL. Each ASL governs hospitals in the territory of competence. Liguria, for the government of technological innovation, approved with a formal act in 2011 (DGR 295) the creation of a Regional HTA Network in order to implement the process of Health Technology Assessment and to develop the concept of Evidence Based Medicine. The main point of the resolution is the introduction of a Mini HTA grid, that must be filled by proponents before the introduction of any technological innovation. Regional HTA Workflow Since 2011 the Ligurian Network Regional HTA Network has Organisation & Role Hospitals require innovative evaluated the following technologies through Mini devices: Director HTA grid compilation 1) Virtual Colonoscopy CAD Coordination group 2) Porcine Dermal Collagen Surgery Consists of all Professionals who Grid submission to Scientific 3) Sling for urinary incontinence may be involved in the Secretariat 4) Collagen Matrix for sutures evaluation, depending on the 5) Fixation device in surgery device to be evaluated: doctors 6) Sterilization devices with different specialisations, Analysis of quality of data 7) Implantable device for Glaucoma clinical engineers, chemists, produced in the grid, 8) Intravascular Catheter context and scientific health economists and 9) Optical Coherence Tomography literature by the Scientific 10) Pneumothorax drainage system representatives of the citizens.
  • Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-Tailed Opossum (Monodelphis Domestica) and North American Opossum (Didelphis Virginiana)

    Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-Tailed Opossum (Monodelphis Domestica) and North American Opossum (Didelphis Virginiana)

    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-2001 Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-tailed Opossum (Monodelphis domestica) and North American Opossum (Didelphis virginiana) Lee Anne Cope University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Animal Sciences Commons Recommended Citation Cope, Lee Anne, "Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-tailed Opossum (Monodelphis domestica) and North American Opossum (Didelphis virginiana). " PhD diss., University of Tennessee, 2001. https://trace.tennessee.edu/utk_graddiss/2046 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Lee Anne Cope entitled "Comparative Anatomy of the Lower Respiratory Tract of the Gray Short-tailed Opossum (Monodelphis domestica) and North American Opossum (Didelphis virginiana)." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Animal Science. Robert W. Henry, Major Professor We have read this dissertation and recommend its acceptance: Dr. R.B. Reed, Dr. C. Mendis-Handagama, Dr. J. Schumacher, Dr. S.E. Orosz Accepted for the Council: Carolyn R.
  • Enteroliths in a Kock Continent Ileostomy: Case Report and Review of the Literature

    Enteroliths in a Kock Continent Ileostomy: Case Report and Review of the Literature

    E200 Cases and Techniques Library (CTL) similar symptoms recurred 2 years later. A second ileoscopy showed a narrowed Enteroliths in a Kock continent ileostomy: efferent loop that was dilated by insertion case report and review of the literature of the colonoscope, with successful relief of her symptoms. Chemical analysis of one of the retrieved enteroliths revealed calcium oxalate crystals. Five cases have previously been noted in the literature Fig. 1 Schematic (●" Table 1). representation of a Kock continent The alkaline milieu of succus entericus in ileostomy. the ileum may induce the precipitation of a calcium oxalate concretion; in contrast, the acidic milieu found more proximally in the intestine enhances the solubility of calcium. The gradual precipitation of un- conjugated bile salts, calcium oxalate, and Valve calcium carbonate crystals around a nidus composed of fecal material or undigested Efferent loop fiber can lead to the formation of calcium oxalate calculi over time [5]. Endoscopy_UCTN_Code_CCL_1AD_2AJ Reservoir Competing interests: None Hadi Moattar1, Jakob Begun1,2, Timothy Florin1,2 1 Department of Gastroenterology, Mater Adult Hospital, South Brisbane, Australia The Kock continent ileostomy (KCI) was dure was done to treat ulcerative pan- 2 Mater Research, University of Queens- designed by Nik Kock, who used an intus- colitis complicated by colon cancer. She land, Translational Research Institute, suscepted ileostomy loop to create a nip- had a well-functioning KCI that she had Woolloongabba, Australia ple valve (●" Fig.1) that would not leak catheterized daily for 34 years before she and would allow ileal effluent to be evac- presented with intermittent abdominal uated with a catheter [1].
  • Group Supplemental Limited Benefit Insurance Plan 2

    Group Supplemental Limited Benefit Insurance Plan 2

    Group Supplemental Limited Benefit Insurance Plan 2 Group Medical BridgeSM* insurance can help with medical costs associated with a hospital stay that your health insurance may not cover. These benefits are available for you, your spouse and eligible dependent children. *The policy name is Group Supplemental Limited Benefit Insurance. Hospital confinement ............................................................... $_______________1,000 per day Maximum of one day per covered person per calendar year Waiver of premium Available after 30 continuous days of a covered confinement of the named insured £ Daily hospital confinement ................................................................... $100 per day Maximum of 365 days per covered person per confinement. Re-confinement for the same or related condition within 90 days of discharge is considered a continuation of a previous confinement. £ Diagnostic procedure .................................................................. $_______________not available per day Maximum of one day per covered person per calendar year £ Outpatient surgical procedure ¾ Tier 1..................................................................................... $_______________500 per day ¾ Tier 2..................................................................................... $_______________1,000 per day Maximum of $________________1,500 per covered person per calendar year for Tier 1 and 2 combined Maximum of one day per outpatient surgical procedure Diagnostic procedures The following is a list
  • Sphincter of Oddi: ERCP Plus Sphincterotomy – Yes Or No

    Sphincter of Oddi: ERCP Plus Sphincterotomy – Yes Or No

    Sphincter of Oddi: ERCP Plus Sphincterotomy – Yes or No Note: For debate purposes, the pro and con positions for patient management will be taken by the invited authors. However, actual decisions regarding patient care must involve discussion of the risks and benefits of each treatment considered. Case Presentation – Case developed by Ihab I. El Hajj, MD, MPH, Indiana University, Indianapolis, IN A 57-year-old Caucasian female with history of smoking and COPD, was in her usual state of health until two years ago, when she experienced recurrent “attacks” of right upper quadrant pain, nausea and occasional vomiting, suggestive of biliary colic. The patient was evaluated by her primary care physician and initial work- up, which included basic blood work, liver chemistries and transabdominal ultrasound, were negative. The patient responded partially to prn Zofran and omeprazole 40 mg once then twice daily. With the persistence of her symptoms, the patient was referred to a gastroenterologist. Esophagogastroduodenoscopy (EGD) with gastric biopsies revealed chronic inactive gastritis without Helicobacter pylori. HIDA scan suggested biliary dyskinesia with an ejection fraction of 22%. An elective laparoscopic cholecystectomy was performed. An intra- operative cholangiogram showed no filling defect in the common bile duct (CBD) and pathology demonstrated chronic cholecystitis with no gallstones. The patient was symptom-free for six months after surgery. She subsequently developed vague upper abdominal pain, intermittent nausea and irregular bowel movements. Labs, colonoscopy and repeat EGD were ASGE Leading Edge — Volume 4, No. 4 © American Society for Gastrointestinal Endoscopy normal. The patient was treated for suspected irritable bowel syndrome. She failed several medications including hyoscyamine, dicyclomine, amitriptyline, sucralfate, and GI cocktail.
  • Mft•] ~;;I~ [I) I~ T?L3 ·Ilr!F·S; [,J ~ M

    Mft•] ~;;I~ [I) I~ T?L3 ·Ilr!F·S; [,J ~ M

    Mft•] ~;;I~ [I) I~ t?l3 ·ilr!f·S; [,j ~ M Hepatobiliary Imaging Update Maggie Chester and Jerry Glowniak Veterans Affairs Medical Center and Oregon Health Sciences University, Portland, Oregon and the gallbladder ejection fraction (EF) after the injection This is the first article in a four-part series on interventional of cholecystokinin (CCK) (Kinevac®, Squibb Diagnostics, nuclear medicine. Upon completion, the nuclear medicine New Brunswick, NJ). A brief description of the hepatic ex­ technologist should be able to (1) list the advantages of using traction fraction (HEF) was given; the technique used quan­ interventional hepatic imaging, (2) identify the benefit in tifies hepatocyte function more accurately than does excretion calculating HEF, and (3) utilize the HEF calculation method when appropriate. half-time. Since publication of the previous article (5), the HEF has become more widely used as a measure of hepatocyte function, and nearly all the major nuclear medicine software vendors include programs for calculating the HEF. Scintigraphic assessment of hepatobiliary function began in In this article, we will describe new observations and meth­ the 1950s with the introduction of iodine-131 C31 1) Rose ods used in hepatobiliary imaging. The following topics will bengal (1). Due to the poor imaging characteristics of 1311, be discussed: ( 1) the use of morphine as an aid in the diagnosis numerous attempts were made to find a technetium-99m 99 of acute cholecystitis, (2) the rim sign in the diagnosis of acute ( mTc) labeled hepatobiliary agent (2). The most useful of cholecystitis, and (3) methods for calculating the HEF. the several 99mTc-labeled agents that were investigated were the iminodiacetic acid (IDA) analogs, which were introduced MORPHINE-AUGMENTED CHOLESCINTIGRAPHY in the mid 1970s (3).
  • ACR Appropriateness Criteria® Right Upper Quadrant Pain

    ACR Appropriateness Criteria® Right Upper Quadrant Pain

    Revised 2018 American College of Radiology ACR Appropriateness Criteria® Right Upper Quadrant Pain Variant 1: Right upper quadrant pain. Suspected biliary disease. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US abdomen Usually Appropriate O CT abdomen with IV contrast May Be Appropriate ☢☢☢ MRI abdomen without and with IV May Be Appropriate contrast with MRCP O MRI abdomen without IV contrast with May Be Appropriate MRCP O Nuclear medicine scan gallbladder May Be Appropriate ☢☢ CT abdomen without IV contrast May Be Appropriate ☢☢☢ CT abdomen without and with IV Usually Not Appropriate contrast ☢☢☢☢ Variant 2: Right upper quadrant pain. No fever or high white blood cell (WBC) count. Suspected biliary disease. Negative or equivocal ultrasound. Procedure Appropriateness Category Relative Radiation Level MRI abdomen without and with IV Usually Appropriate contrast with MRCP O CT abdomen with IV contrast Usually Appropriate ☢☢☢ MRI abdomen without IV contrast with Usually Appropriate MRCP O Nuclear medicine scan gallbladder May Be Appropriate ☢☢ CT abdomen without IV contrast May Be Appropriate ☢☢☢ CT abdomen without and with IV Usually Not Appropriate contrast ☢☢☢☢ Variant 3: Right upper quadrant pain. Fever, elevated WBC count. Suspected biliary disease. Negative or equivocal ultrasound. Procedure Appropriateness Category Relative Radiation Level MRI abdomen without and with IV Usually Appropriate contrast with MRCP O CT abdomen with IV contrast Usually Appropriate ☢☢☢ Nuclear medicine scan gallbladder Usually Appropriate ☢☢ MRI abdomen without IV contrast with May Be Appropriate MRCP O CT abdomen without IV contrast May Be Appropriate ☢☢☢ CT abdomen without and with IV Usually Not Appropriate contrast ☢☢☢☢ ACR Appropriateness Criteria® 1 Right Upper Quadrant Pain Variant 4: Right upper quadrant pain.
  • Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement

    Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement

    Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement Harvey A. Ziessman, MD; Douglas A. Jones, MD; Larry R. Muenz, PhD; and Anup K. Agarval, MS Department of Radiology, Georgetown University Hospital, Washington, DC Fatty meals have been used by investigators and clini- The purpose of this investigation was to evaluate the use of a cians over the years to evaluate gallbladder contraction in commercially available lactose-free fatty-meal food supple- conjunction with oral cholecystography, ultrasonography, ment, as an alternative to sincalide cholescintigraphy, to de- and cholescintigraphy. Proponents assert that fatty meals velop a standard methodology, and to determine normal gall- are physiologic and low in cost. Numerous different fatty bladder ejection fractions (GBEFs) for this supplement. meals have been used. Many are institution specific. Meth- Methods: Twenty healthy volunteers all had negative medical histories for hepatobiliary and gallbladder disease, had no per- odologies have differed, and few investigations have stud- sonal or family history of hepatobiliary disease, and were not ied a sufficient number of subjects to establish valid normal taking any medication known to affect gallbladder emptying. All GBEFs for the specific meal. Whole milk and half-and-half were prescreened with a complete blood cell count, compre- have the advantage of being simple to prepare and admin- hensive metabolic profile, gallbladder and liver ultrasonography, ister (4–7). Milk has been particularly well investigated. and conventional cholescintigraphy. Three of the 20 subjects Large numbers of healthy subjects have been studied, a were eliminated from the final analysis because of an abnormal- clear methodology described, and normal values determined ity in one of the above studies.
  • The Diagnosis of Acute Cholecystitis: Sensitivity of Sonography

    The Diagnosis of Acute Cholecystitis: Sensitivity of Sonography

    The Diagnosis of Acute Cholecystitis: Sensitivity of Sonography, Cholescintigraphy and Computed Tomography Patthisak Changphaisarnkul MD*, Supakajee Saengruang-Orn PhD*, Trirat Boonya-Asadorn MD* * Division of Radiology, Phramonkutklao Hospital, Bangkok, Thailand Objective: To compare the sensitivity of sonographic, cholescintigraphic, and computed tomographic examination of acute cholecystitis to the pathology result, which is considered the Gold Standard. Material and Method: A retrospective analytic study was conducted among 412 patients, aged between 15 and 98 years, who underwent cholecystectomy surgeries, and whose pathology results indicated acute cholecystitis between July 2004 and May 2013. The sensitivity and the differences between sensitivity of the three methods were calculated in all patients. Complicated acute cholecystitis cases were analyzed separately. Results: The three methods demonstrated statistically significant differences in sensitivity (p-value = 0.017), with the cholescintigraphy as the most sensitive method (84.2%), followed by computed tomography (67.3%), and sonography (59.8%). Concerning the samples with the pathology result indicating complicated acute cholecystitis, computed tomography was statistically significantly more sensitive than sonography in detecting acute cholecystitis, whether or not the complications were identified (100% and 63.6%, respectively, with p-value = 0.0055). None of the patients with the pathology result of complicated acute cholecystitis case was examined by cholescintigraphy, thus, no calculation was possible. Regarding the ability to detect the complications of acute cholecystitis, computed tomography had a sensitivity of 35.71% (5 in 14 patients), while sonographic examinations could not detect any of the complications. Conclusion: Cholescintigraphy is a more sensitive method than computed tomography and sonography, but the three methods have its own advantages, disadvantages, and limitations, which must be considered for each individual patient.
  • Imaging Indication Guidelines

    Imaging Indication Guidelines

    IMAGING INDICATION GUIDELINES Your partner in outpatient radiology We are dedicated to achieving the highest levels of quality and safety in outpatient imaging. We developed these Imaging Indication Guidelines to help you choose imaging examinations that will answer your clinical questions for your patients. We hope they will assist you in the pre-authorization and Medicare Appropriate Use Criteria processes. Quality Convenience Affordability High quality reports Appointments when and Reduce your out-of-pocket and equipment where you need them imaging cost 2 | IMAGING INDICATION GUIDELINES Notes IMAGING INDICATION GUIDELINES | 3 Notes 4 | IMAGING INDICATION GUIDELINES We are dedicated to achieving the highest levels of quality and safety, and have developed these Imaging Indication Guidelines to provide information and guidance during the radiology ordering process. General Contrast Guidelines Choose “Radiologist Discretion” on the order and our board certified radiologists will select the contrast option suited to your patient’s history and condition. This will facilitate thepre -authorization process. Generally, contrast is indicated whenever you are concerned about: • Infection (except uncomplicated sinusitis) • Organ integrity • Tumor or cancer • Possible disc after lumbar surgery • Vascular abnormality (except stroke) Generally, contrasted MRI scans are performed with and without contrast. Generally, CT scans are performed either with or without contrast in order to limit the patient’s radiation dose. Without & with contrast CT scans are indicated for these conditions: • Thoracic aortic dissection • Kidney mass • Liver mass • Painless hematuria • Pancreas mass • Bladder mass • Adrenal gland mass Exams Commonly Confused: • Cervical CT or MRI (for vs. Soft tissue neck CT or MRI (for soft cervical spine) tissue, e.g.
  • Review on Lithotripsy and Cavitation in Urinary Stone Therapy Morteza Ghorbani, Ozlem Oral, Sinan Ekici, Devrim Gozuacik, and Ali Kos¸Ar

    Review on Lithotripsy and Cavitation in Urinary Stone Therapy Morteza Ghorbani, Ozlem Oral, Sinan Ekici, Devrim Gozuacik, and Ali Kos¸Ar

    264 IEEE REVIEWS IN BIOMEDICAL ENGINEERING, VOL. 9, 2016 Review on Lithotripsy and Cavitation in Urinary Stone Therapy Morteza Ghorbani, Ozlem Oral, Sinan Ekici, Devrim Gozuacik, and Ali Kos¸ar (Clinical Application Review) Abstract—Cavitation is the sudden formation of vapor particles around their initial positions, resulting in local changes bubbles or voids in liquid media and occurs after rapid in liquid pressure. Depending on the frequency, the level of changes in pressure as a consequence of mechanical acoustical energy and/or pressure can be targeted to the desired forces. It is mostly an undesirable phenomenon. Although the elimination of cavitation is a major topic in the study area, thereby enabling the use of ultrasound in therapeutic appli- of fluid dynamics, its destructive nature could be exploited cations. Because of its ability to exert localized energy from sur- for therapeutic applications. Ultrasonic and hydrodynamic face of the skin into soft tissues, ultrasound has attracted much sources are two main origins for generating cavitation. The interest as a noninvasive and targeted therapeutic treatment [1]. purpose of this review is to give the reader a general idea According to the exposure conditions such as frequency, pres- about the formation of cavitation phenomenon and exist- ing biomedical applications of ultrasonic and hydrodynamic sure, or duration, ultrasound can prompt thermal, acoustic radia- cavitation. Because of the high number of the studies on ul- tion force, and cavitational effects, which are important parame- trasound cavitation in the literature, the main focus of this ters to improve therapeutic effectiveness of ultrasonic cavitation review is placed on the lithotripsy techniques, which have in various biomedical applications [2]–[5].
  • Magnetic Resonance Cholangio-Pancreatography in Patients with Acute Cholecystitis and Cholestatic Liver Pattern - What to Expect?

    Magnetic Resonance Cholangio-Pancreatography in Patients with Acute Cholecystitis and Cholestatic Liver Pattern - What to Expect?

    Jemds.com Original Research Article Magnetic Resonance Cholangio-Pancreatography in Patients with Acute Cholecystitis and Cholestatic Liver Pattern - What to Expect? Ali Al Orf1, Khawaja Bilal Waheed2, Ali Salman Alshehri3, Mushref Ali Algarni4, Bilal Altaf5, Muhammad Amjad6, Ayman Abdullah Alhumaid7, Zechariah Jebakumar Arulanantham8 1Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 2Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 3Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 4Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 5Department of General Surgery, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 6Department of Internal Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 7Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 8Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia. ABSTRACT BACKGROUND Acute cholecystitis is a potentially serious condition and usually needs to be treated Corresponding Author: in the hospital. Identification of a common bile duct (CBD) stone before Khawaja Bilal Waheed, Consultant General Radiologist, cholecystectomy is of concern for the treating physicians as management may King Fahad Military Medical Complex, change. Magnetic Resonance Cholangiopancreatography (MRCP) can help in Dhahran, Saudi Arabia. identifying causes of biliary obstruction (if present) and adequately delineate biliary E-mail: [email protected] tree in selected patients with limited or abnormal ultrasounds and cholestatic liver DOI: 10.14260/jemds/2020/530 pattern. Therefore, we aim to demonstrate imaging findings of MRCP in such patients of acute cholecystitis, and highlight the diagnostic ability of MRCP in biliary ductal How to Cite This Article: evaluation as well.